HEPCDAC 60MG TABLET (DACLATASVIR)

Brand name – Hepcdac

Generic name – Daclatasvir

Salt composition – Daclatasvir 60 mg

Manufacturer – Cipla Ltd

Dosage form – Oral (tablet)

Packaging – Bottle of 28 tablets

Indication – Used in the treatment of chronic Hepatitis C Virus (HCV) infection

Storage – Store at room temperature (10-30°C)

Strength – 60 mg

Gender – Unisex

Prescription required – Yes

Description
Hepcdac 60 mg (Daclatasvir) is an antiviral medication, which is used with other

medications in the treatment of chronic Hepatitis C Virus (HCV) infection in adults. This

antiviral medicine helps to lower the multiplication of the virus in the blood and thereby,

improves liver function over a period of time. The active ingredient of Hepcdac is

Daclatasvir.

Pharmacodynamics
The combination of daclatasvir (DCV), sofosbuvir (SOF), and ribavirin (RBV) is a direct-

acting antiviral (DAA) regimen for the treatment of hepatitis C virus (HCV) infection.

That is why this medication is given with other medications to treat the Hepatitis C Virus.

The inclusion of newer effective DAAs such as SOF and DCV with high efficacy and

excellent tolerance introduced a new way in HCV infection therapy: high rates of

sustained virological response (SVR), shorter therapies, less toxicity, and interferon-free

treatments.

Contraindications
Do not consume this medication if you have an allergy to any ingredient of Hepcdac 60

mg tablet.

Alternate brands

● Hepcfix 60 mg tablet

● Daclacure 60 mg tablet

● Natdac 60 mg tablet

● Dalsiclear 60 tablet

● Daclahep 60 mg tablet